Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRANSIT: Ustekinumab Transition Strategies in Psoriasis
NCT01059773Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Oct 2009
- Primary completion
- Nov 2010
- Modality
- Monoclonal Antibodies
- Countries
- 19
01
Overview
A Phase 4 trial of ustekinumab in plaque psoriasis, sponsored by Janssen Pharmaceutical. Started Oct 2009; status: completed.
02
Drugs
ustekinumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01059773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01059773.